Journals / Turkish Thoracic Journal / 2015 / Cilt: 16 - Sayı: 2

Does total parenteral nutrition increase the mortality of patients with severe sepsis in the ıcu?

Pages
53–58
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Rational use of antibiotics and application of hospital acquired infection control program will further reduce mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: We aimed to evaluate the independent association between total parenteral nutrition (TPN) and nosocomial infection and intensive care unit (ICU) mortality in patients with severe pulmonary sepsis.
📊
Key Findings & Data:We enrolled all patients with severe sepsis due to pulmonary infections who stayed more than 24 h in the respiratory ICU between January 2009 and December 2010.
💡
Conclusion & Impact:Rational use of antibiotics and application of hospital acquired infection control program will further reduce mortality.
🔬Design:Modeling & Simulation
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES: We aimed to evaluate the independent association between total parenteral nutrition (TPN) and nosocomial infection and intensive care unit (ICU) mortality in patients with severe pulmonary sepsis. MATERIAL AND METHODS: The present study was designed as a retrospective observational cohort study. We enrolled all patients with severe sepsis due to pulmonary infections who stayed more than 24 h in the respiratory ICU between January 2009 and December 2010. We recorded demographic characteristics, ICU severity scores, Acute Physiologic and Chronic Health Evaluation II (APACHE II) and frst day Sequential Organ Failure Assessment (SOFA) score in the ICU, TPN because of intolerance to enteral feeding, ICU data, and mortality. To evaluate the risk factors for mortality, we performed adjusted logistic regression test for TPN, nosocomial infection, and SOFA in the model. RESULTS: Five hundred and ffty patients (males=375, females=175) with severe sepsis were involved in the study during the study period. The median and interquartile range (IQR) of age, APACHE II, and SOFA score at the time of admission to the ICU were 65 years (53-73), 20 (16-25), and 4 (3-6), respectively. Mortality rate was 18% (n=99). Adjusted odds ratio (OR), confdence intervals (CI) 95%, and p values of TPN, nosocomial infection, and frst day SOFA score for mortality were as follows: OR:3.8, CI:2.3-6.1, p<0.001; OR:2.4, CI: 1.4-3.9, p<0.001; and OR: 1.3, CI:1.2-1.4, p<0.001, respectively. CONCLUSION: Nosocomial infection and the need for TPN because of intolerance of enteral nutrition (EN) is associated with a higher mortality rate in patients with severe sepsis in the ICU. Rational use of antibiotics and application of hospital acquired infection control program will further reduce mortality.

🔖

Cite This Article

TAKIR, H. B., KARAKURT, Z., SALTÜRK, C., BALCI, M. K., KARGIN, F., YAZICIOĞLU, Ö. M., GÜNGÖR, G., ÇELİK, E., DEVRAN, Ö., YALÇINSOY, M., ÖZMEN, İ., ADIGÜZEL, N. (2015). Does total parenteral nutrition increase the mortality of patients with severe sepsis in the ıcu?. Turkish Thoracic Journal, Cilt: 16 - Sayı: 2, 53–58. https://ajindex.com/articles/418158

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992
  2. [CrossRef] 2. Vincent JL, Abraham E, Annane D, et al. Reducing mortality in sepsis: new directions. Crit Care 2002
  3. 6(Suppl 3):1-18. [CrossRef] 3. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Cam- paign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004
  4. [CrossRef] 4. Levy MM, Dellinger RP, Townsend SR, et al. The surviving sepsis campaign: Results of an international guideline-based perfor- mance improvement program targeting severe sepsis. Crit Care Med 2010
  5. [CrossRef] 5. Martin CM, Priestap F, Fisher H, et al. A prospective, observa - tional registry of patients with severe sepsis: The Canadian Sepsis Treatment and Response Registry. Crit Care Med 2009
  6. [CrossRef] 6. Peake SL, Bailey M, Bellomo R, et al. Australasian resuscitation of sepsis evaluation (ARISE): A multi-centre, prospective, incep- tion cohort study. Resuscitation 2009
  7. [CrossRef] 7. Trzeciak S, Dellinger RP, Abate NL, et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency depart- ment. Chest 2006
  8. [CrossRef] 8. Westphal GA, Koenig Á, Caldeira Filho M, et al. Reduced mor- tality after the implementation of a protocol for the early detec- tion of severe sepsis. J Crit Care 2011
  9. [CrossRef] 9. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare- associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epide - miol 2008
  10. [CrossRef] 10. Karakurt Z, Yarkın T, Adıgüzel N, et al. Implication of a sepsis protocol in a respiratory intensive care unit: a 12 month experi- ence. Yoğun Bakım Derg 2010
  11. [CrossRef] 11. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Cam- paign: international guidelines for management of severe sep- sis and septic shock: 2008. Crit Care Med 2008
  12. [CrossRef] 12. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit C